Delfinis, L. J., Khajehzadehshoushtar, S., Flewwelling, L. D., Andrews, N. J., Garibotti, M. C., Gandhi, S., . . . Perry, C. G. Mitochondrial-targeted plastoquinone therapy prevents early onset muscle weakness that occurs before atrophy during ovarian cancer. Elsevier.
Chicago Style (17th ed.) CitationDelfinis, Luca J., et al. Mitochondrial-targeted Plastoquinone Therapy Prevents Early Onset Muscle Weakness That Occurs Before Atrophy During Ovarian Cancer. Elsevier.
MLA (9th ed.) CitationDelfinis, Luca J., et al. Mitochondrial-targeted Plastoquinone Therapy Prevents Early Onset Muscle Weakness That Occurs Before Atrophy During Ovarian Cancer. Elsevier.
Warning: These citations may not always be 100% accurate.